Comparison of Two Approaches of Quadratus Lumborum Block for Post-operative Analgesia in Radical Cystectomy

July 30, 2024 updated by: Hassan mostafa abdelbaky ahmed, Assiut University

Comparison of Two Approaches of Quadratus Lumborum Block for Post-operative Analgesia in Radical Cystectomy: Prospective-randomized Clinical Trial

To compare the postoperative analgesic effect of two ultrasound guided approaches of quadratus lumborum block (QLB) (anterior and intramuscular) for radical cystectomy.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The quadratus lumborum block (QLB) is one of the abdominal wall block techniques used to anesthetize thoracolumbar nerves . The QLB technique was described initially by Blanco et al. in 2007 (not published), then reported initially by Kadam in 2013. Since then, QLB has evolved with the development of the ultrasound-guided nerve block. To date, several randomized controlled trials have reported effective postoperative analgesia, with non-intramuscular QLB for cesarean sections, laparoscopic gynecologic surgery and hip hemiarthroplasty .

The intramuscular QLB (QLBi) technique was first reported by. This approach is different from others in tubouchi for QLB; although the injection target sites of the other approaches are planes around the quadratus lumborum muscle, the intramuscular approach penetrates the fascia of the quadratus lumborum muscle, where local anesthetics are injected. Therefore, QLBi is relatively easier to perform compared with other QLB approaches.

The incidence of urinary bladder cancer in the Middle East and Africa is greater in areas with high rather than low SH prevalence.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Abdel raheem Mahmoud Mohamed, Prof
  • Phone Number: 01000032655

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age: 40-70years.

    • BMI: 20-30 kg.m2
    • Sex: both males and females.
    • American Society of Anesthesiologists (ASA )physical status: I-III.
    • Operation: radical cystectomy

Exclusion Criteria:

  • • Patient's refusal to participate in the study.

    • known allergy to local anesthesia (LA),
    • coagulopathy or thrombocytopenia,
    • body mass index (BMI) above 30 kg .m 2, and infection at site of injection.
    • Chronic pain syndromes,
    • Prolonged opioid medication,
    • Patients on regular use of analgesic or who received analgesic 24 h before surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1 (QLBA) will include 30 patients
will receive ultrasound-guided anterior approach quadratus lumborum block
using 2.5mg/kg of 0.25% bupivacaine diluted in a 20 mL syringe of normal saline , received ultrasound-guided quadratus lumborum.
Experimental: Group 2 (QLBI)will include 30 patients.
received ultrasound-guided intramuscular quadratus lumborum.
using 2.5mg/kg of 0.25% bupivacaine diluted in a 20 mL syringe of normal saline , received ultrasound-guided quadratus lumborum.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the first call for rescue analgesia
Time Frame: 24hours after recovery From anesthesia
The time of the first call of analgesia is recorded
24hours after recovery From anesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total doses of morphine required
Time Frame: 24hours after recovery from anesthesia
Doses of morphine required postoperative
24hours after recovery from anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2021

Primary Completion (Estimated)

September 4, 2024

Study Completion (Estimated)

September 25, 2024

Study Registration Dates

First Submitted

May 22, 2021

First Submitted That Met QC Criteria

October 10, 2021

First Posted (Actual)

October 22, 2021

Study Record Updates

Last Update Posted (Actual)

July 31, 2024

Last Update Submitted That Met QC Criteria

July 30, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 01060264751

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quadratus Lumborum Block

Clinical Trials on US guided injection

Subscribe